ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel

D. Maluf, R. Gehrau, J. Suh, K. Brayman, C. Bustamante, M. Edmunds, P. Darvishi, V. Mas.

UVA, Charlottesville, VA.

Meeting: 2015 American Transplant Congress

Abstract number: C245

Keywords: FK506, Genomic markers

Session Information

Session Name: Poster Session C: Translational Biomarkers and Immune Monitoring

Session Type: Poster Session

Date: Monday, May 4, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Background: We previously described a gene expression signature as biomarker of calcineurin inhibitor nephrotoxicity (CNIT) post renal transplantation. Herein, we aimed to validate the same set of markers in urine samples of liver transplant (LT) recipients under CNI therapy with renal function impairment.

Methods: This study included 52 urine samples collected during routine clinical follow-up visit from 42 LTx patients under Tacrolimus (Tac) based immunosuppression. LTx patients were classified according to an estimated glomerular filtration rate (eGFR) as with suspected CNIT (eGFR ≤ 40; n = 23) and non-CNIT (eGFR > 40; n = 29). Urine pellets were obtained by centrifugation and total RNA was isolated following Trizol protocol. Ten genes associated with renal transplant CNIT were tested using real time quantitative PCR (RT-qPCR). Pairwise comparisons (CNIT vs. no-CNIT) for individual gene were performed using two-sample t-test. Demographics-clinical parameters statistical analyses were performed using ANOVA. P-values <0.05 were considered significant. Sample group prediction analysis was performed by discriminant multivariate methods. ROC curves were calculated for each group.

Results: Liver transplant patient groups were homogeneously distributed regarding follow-up time post-LTx and liver function test. Patients with suspected CNIT revealed significant increased BUN, Creatinine and decrease in eGFR. Mean eGFR values were 37.0±6.4 and 58.4±6.3 for CNIT and no-CNIT, respectively. Peripheral blood Tac levels were no significantly different between groups . From the evaluated molecular panel, 7 genes (SCL13A3, AQP1, AQP2, NPHS2, CUBN, LPR2, and SCL12A3) were found significantly down regulated in CNIT urine pellets. The gene expression panel was able to accurately distinguish 76.9% (40/52) of samples depending on the assigned study group. Calculated diagnostic sensitivity, specificity, and positive and negative predictive values for the gene expression panel to distinguish between groups were 76%, 77%, 70%, and 83%, respectively. Areas under ROC curve were 0.85 for both study groups. All patients demonstrated an improvement in eGFR decreasingTacrolimus doses.

Conclusions: We validated a CNIT urine biomarker set (previously described in KT patients) in LTx recipients with post-transplant renal impairment under CNI therapy. The validated biomarker set demonstrated high diagnostic sensitivity and specificity.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Maluf D, Gehrau R, Suh J, Brayman K, Bustamante C, Edmunds M, Darvishi P, Mas V. Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/biomarker-for-calcineurin-inhibitors-nephrotoxicity-in-solid-organ-transplantation-validation-of-a-urine-gene-expression-panel/. Accessed May 9, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences